Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200

Clinical trial NCT05034874 · TERMINATED

Trial details

NCT number: NCT05034874
Sponsor: InterveXion Therapeutics, LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Methamphetamine-dependence Methamphetamine Abuse

Start date: 2022-06-09
Primary completion: 2023-09-11
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.